1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €1.29 (-40.00%). The median is €1.29 (-40.00%).
| Buy |
1 |
| Hold |
2 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | 0 | 100.00% |
| Net profit | -1.36M | 9.27% |
| EBITDA | -1.29M | 5.20% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.13M |
Number of shares | 526.71K |
52-week high/low | €84.15 - €1.87 |
| Dividends | No |
Beta | 1.44 |
P/E ratio | -0.21 |
PEG ratio | 0.00 |
P/B ratio | 0.18 |
P/S ratio | 0.00 |
Company profile
| Name | Aethlon Medical |
| CEO | James Frakes |
| Employees | 9 |
Discover assets
Shareholders of Aethlon Medical also invest in the following assets
